These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 9218667)

  • 1. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
    Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
    JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
    JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
    Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
    JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
    Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
    Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
    Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
    Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between chlorthalidone treatment of systolic hypertension and long-term survival.
    Kostis JB; Cabrera J; Cheng JQ; Cosgrove NM; Deng Y; Pressel SL; Davis BR
    JAMA; 2011 Dec; 306(23):2588-93. PubMed ID: 22187278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
    Petrovitch H; Vogt TM; Berge KG
    Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
    Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
    Applegate WB; Pressel S; Wittes J; Luhr J; Shekelle RB; Camel GH; Greenlick MR; Hadley E; Moye L; Perry HM
    Arch Intern Med; 1994 Oct; 154(19):2154-60. PubMed ID: 7944835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
    Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
    J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.
    Kostis JB; Wilson AC; Freudenberger RS; Cosgrove NM; Pressel SL; Davis BR;
    Am J Cardiol; 2005 Jan; 95(1):29-35. PubMed ID: 15619390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment of isolated systolic hypertension on left ventricular mass.
    Ofili EO; Cohen JD; St Vrain JA; Pearson A; Martin TJ; Uy ND; Castello R; Labovitz AJ
    JAMA; 1998 Mar; 279(10):778-80. PubMed ID: 9508155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.